Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

LBA59 LMS-04 study: A randomised, multicenter, phase III study comparing doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin in non-progressive patients as first-line therapy, in patients with metastatic or unresectable leiomyosarcoma - A French Sarcoma Group study

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • بيانات النشر:
      Elsevier BV, 2021.
    • الموضوع:
      2021
    • ISSN:
      0923-7534
    • الرقم المعرف:
      10.1016/j.annonc.2021.08.2139
    • Rights:
      OPEN
    • الرقم المعرف:
      edsair.doi...........7b53eb991933214cef9840a7d8c418b1